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HB1 
EXPRESSION OF CC R-5, BUT NOT CXCR-4, ON FUESHL Y ISOLA TED 
LANGERHANS CELLS CORRELAT ES WITH RESTRI CT ED TRANS-
MISSION OF MACROI'HAGE-TROPIC HIV. ~.' M Zajtseva,2 JE 
~~ C Lapham ,2 J M;wjsc hcwj !z,2 V Klaus-Kovtun , l H Go ldinc .1 
1 Denna10logy Branch, NCI nnd 'Division of Viral Producls. FDA. Belhesda, MD. 
Sexual transmission of 1-UV is restricted to macrophage (M~~)- t ropic strains of virus, 
although the basis for this phenomenon is unknown. Recently, the chcmoki nc receptors 
CCR-5 and CXCR-4 have been shown 10 be the major HTV co-reccplors for M¢-lropic 
and T cclllint!- tropic variants of HIV, respect ively. Since Langcrhans ce lls (LC) have 
been proposed to be the firs t cdltypc infec ted following mucosal exposure to HlV, th l!. 
aim of this study was to determine whi.!thcr restricted transmission of M~-tropic HIV 
correlaJcd with the pauern of HIV co-receptor express ion o n LC. We gent! ratcd 
polyclonul rabbil sera containing antibod ies direc ted against the cxtracclluhlr N-te rmini 
of CCR-5 and CXCR-4, and confirmed the specific ity of th e. anti se ra using a functi onal 
fusion assay . We then immunolabclcd freshl y isolated and cultured humun epide rmal 
LC (derived from suction blister roofs) for cell surface expression of CCR-5 and 
CXCR-4 wi th these antisera. using a sens iti ve 3-s tcp staining pro tocol and tlow 
cytomeu-ic analyses. Freshly isolalcd LC expressed CCR-5 (24 -49%). btU nol CXCR-4. 
1l1c absence of CXCR-4 on f reshly isolated LC was no t due to trypsin sensitivity. In 
contrast, I day cultured LC expressed both HlV co-receptors (28-53% for CCR-5 and 
16-43% for CXCR-4). On 2 day cuhurc.d LC, y- interfc ron (20 ng/ml) pr~ vcntcd 
expression ofCXCR-4, whereas TNF-n (20 ng/ml) and GM·CSF (1.000 U/ml) did not 
significanlly affect cilher CCR-5 or CXCR-4 expression. This is 1he firsl sllldy Ia 
examine HIV co-receptor expression on freshly iso lated LC, and to examine <:ytok ine 
regulation or co-receptor expression. The fact that freshly isolated epidenn~t l LC 
(which rese mble mucosa l LC in si tu) expr~.~ss CCR-5, but not CXCR-4, provides a 
possible explanation for the restricted sexual transmis~ion of M,.,_tropic strains of HlV. 
HBS 
THE MOLECU LAR BASIS OF COWDEN'S SYNDROME. 1-1. C. Tsou X. 
Pi ng. X. X ic Y. Yao. C. Schrage r. A. Gruener A .M. C hri !-i tiano D. Liaw. R. 
P~1rsons C. Eng* and M. Peacocke· Departments of Dcnnatology. Med i~.;i 11e at1d 
Patho logy, Colum bia Uni versity, New York , N.Y .. and the Dana-Farbe r Cancer 
JnsliJul c*. Boslon. MA. 
Cowden's Syndrome (CS) or multiple hamartl)llla :::;yndromc, i ~ an autOS1)1llal 
dominant disorder charac terized by a \"UI'i CI)' 0 1" beni gn Skin les ions, md uding 
tdchilcmmomas. beni gn breas t lesions and an increased ri sk of brca~ t ~.:a nccr. Ti s~ uc 
speci fic G UH.:Cf StiSCC p libil il y is U}!-.'0 illCI'C<.!SCJ ror t!JC thyroid glanJ .. al though tillS C~lllCCf 
ri sk is far less thun for the breast. A subpo pulatio n of CS patiems arc a lso at ri sk for the 
dcYclopmcnt of an unusual rorm of brai n h;mtano ma, ~ ~ dysplasti c g~mgl icx:.y toma. 
Linkage anal ys is prc\' i l)usl y identified a locus for CS at chromoSl.11llC lOq:D. A gene 
encoding a nlwe! pro1ci n tyrosine pltosp/mtasc has recently been identified <H this ,1\amc 
lllC li S. As thi s famil y o r genes has been implico.\lcd in tunwr suppreSS! Oil , \\'C dC\'I:;cd a 
nnuation scree ning s tr;.1 tcgy for the Jiff'crcnt C:\ons or thi s phosphat;,1sc. We 11 :1\c no w 
iden tified 2 no n::;cnsc mutations nnd '.?. missense mutations in certain o f the CS fami li es 
that arc linked to th is region. These sequence differences arc not C\ 'idcnt in th.Jrmal 
im.lidtlua ls. Ho wever, we have a series of CS famili es with L'.lassic s kin fi ndings :md 
earl y onset breast cunccr which do appear nnt appear to be linked to 10y2. , and do no t 
have mutations in the cOOing sequence of this phosphatase. S~.:rccning a se ri es nr other. 
isola ted CS pa ti en t.s with breas t co.mcer also failed to identiry mutations in thi s gene. 
These data dcmon:\tr~1tc that mutatio ns in thi s phosphat~i.'iC appc;.lr to ~1ssoc int cd with 
certain individ uul s \\'ith CS. There arc o the r families lhat ~1rc. not linkci.l to \Oq23 and do 
not luwc mutat ions in this phosphuwse. The mututions in this phosphatase arc the fin;t 
mutati nns assoc iutcd wit h CS. howeve r, it i}: likely that CS is gene ti ca ll y l1Cterogc!H'>t1S 
and o the r genes a rc involved in thc dC\"C\opmcnt or breas t c~mccr in CS. 
HB21 
IDENTIFICATION OF A NOVEL HUMAN SKIN-DER IVED ANTIMICROBIAL PEPTIDE. 
J. Hard er. J . Bartels E. Christophers J.-M. SchrOder, Department of Dermatology, 
University of Kiel, D-24 105 Kiel, FRG 
Epithelial ce lls of vertebrates and invertebrates as well as plants are known to 
prevent bacterial, fung al as well as vi ral infection by the relea se of antimicrobial 
peptides which kill infectious orga nisms by forming pores. Since little is known about 
this innate immunity system in man, we addressed the question , whether also 
human skin is capable of producing similar antimicrobial peptides. 
Because psoriatic patients have an unexpected low skin infection rate, we speculated 
w hether active psoriatic skin and scales might be a potent ial source of antimicrobia l 
peptides. Therefore we separated psoria t ic scale extracts by reversed phase HPLC 
techniques and tested antimicrob ial (E.coli) activity in fractions by the use of a plate 
assay. As a result we obtained severa l peaks of antimicrobial act iv ity . A majo r one 
termed "skin derived ant imicrobia l peptide (SAP-1 )"was purified to homogeneity and 
further analyzed biochemical ly . As a result we found SAP· 1 to be a nove14 kD pepti · 
de having a sequence homology to mammal ant imicrobial f3·defensins. SAP-1 was 
found to be highly effective in killing gram negative bacteria and C(mdida albicans 
(LDao= 1 OJJg /ml). Using degenerated prim ers we were able to isolate the complete 
SAP-1 eDNA from the human keratinocyte ce ll line HaC at proving keratinocytes as 
a potential ce llu lar source of SAP· 1. SAP-1 mANA is present in human skin , trachea 
and lung and is upregulated in cultured normal keratinocytes by TNF·a and strong ly 
increased in the presence of hea t kill ed gram positive, gram nega tive bacteria as well 
as Candida albicans. 
Our observat ion indicates act ive pa rticipation of hum an keratinocyte s in innate 
immunity by producing antimicrob ial peptid es thus allowing homeostasis of bac terial 
co loniza tion on skin . 
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MURINE CLIT ANEOUS MASTOCYTOSIS AND EPIDERMAL MELANOCYTOSIS 
lr.~~~';;? ~ru~,~~ Ttt~fil~hr;:;~.~Fct~r ~~<;;~?~j~,7ta~~sloN~ Takahi ro 
Nishjkmya>. Masako 1Vf1zoguchfi Shin-ichi Ha~ Lyn~a T)'rrcll2 ghY!ckh1 
Longley-; l Dcpl. lmmunol, Totlori Uni v., Yonago, Japan ; De pl. of Dcm1 and Skin 
Disease Rescargh Ctr .. Yale Univ., New Haven, Cf;SDept. Mol. Gen. , Kyoto Univ .. 
Kyoto, Japan; Dept. Dermatol. , St. Marianna Univ., Kawasaki. Japan. 
The growth and di!Tcrcntiation of mast cell s and mclanocytes require stem cell factor 
(SCF) , lhc li gand for the kil receptor 1yros ine kinase. SCF is produced by human bul 
not murine epidermal keratinocytcs, and may exist as a membrane-bound or soluble 
molecule. Abnommlitics of the SCF-kit signalling pathway have been implicated in the 
pathogenesis of the human di sease mas tocytosis , but the cause o f mastocytosis has not 
been demonstrated c..xpcrimcntally. To investigate both the potential of SCF to cause 
mastocytosis and its role in e pidermal melanocyte homeostasis, we targeted lhe cxprcs· 
sian of SCF to epidcmml kcratinocytcs in mice with trnnsgcncs controlled by the human 
keratin 14 promoter. The transgencs contai ned cDNAs which eithe r produced SCF 
which is both mcmbnmc-bound and soluble, or SCF that is predominantly membrane-
bound. Epidcm1al keratinocytc expression of both membrane and soluble SCF rcpm-
duccd the phenotype of hunnm cutaneous mastocytosis in mice, with dermal mast cell 
infiltmtcs and epidcmml hypcrpigmcnta tion, and caused the maintenance of a population 
of cpidcmla.l mc /anocytcs. Kcralinocytc expression of membrane-bound SCF did not 
by itself cause mas tocytosis but resulted in the presence of melanocytcs and excess 
melanin in the intcmd nexal cpidcm1is. an area where lhey arc found in human ski n but 
not usuaJl y in murine skin. We conclude , f1rs t, that a phenotype matching that o f 
human mastocytosis can be produced in mice by kcratinocytc overproduction of both 
membrane and soluble SCF, suggesting a mechanism for the cause o f thi s di sc.'lSC. 
Second, \\'c conclude tiH\l murine keratinocytc express ion of mcmbrnnc·bound SCF 
results in the maintenance of epidcnnal mclnnocytcs. 
HB9 
GENE INTRODUCTION OF ANG IOSTATIN INHIBITS TUMOR GROWTH IN A MO USE MODEL 
Of LIFE·THREATENING HEMANG IOMA . Brian l annuui and Amy S. Paller, O~pnrllncncs of 
Pcdi :urics and Dcnmu ology. Northwestern University Medical School. Chicago. fL. 
Angiostatin , a cle:wage product of plasminogen, is a newly described pO!clll :mtiangiogcnic agent, 
Systemic administr:-uion of angiosl:uin protein to mi ce with malignanc ic~ inhibit s tumor metastases . 
Hemangiomas arc common endothelial cell tumcm; of inf.mcy that may be lifc· thrc:ucning. cspecinlly 
if Kasabach-Mcrrin syndrome develops . ln!crfcn'nHl' . n weak allli ·angiogcni c agent , is considered the 
dl\lg o f choice . but has rccctllly been shown to cause neurotox icity . We have used a mouse model of 
1hc Kasabach-Mcrriu syndrome to test our hypothesis th:tl local producti on Qf angiosttttin inhibits 
hemangioma growlh , decreases the <tSsoc i;ucd thrombocytopenia , and increases survival . t<.•louse 
hcmangiocndmhelioma (EOM A) cel l :~ were st:tbly u :msfeelcd by lipofceti on with mouse angiostatin 
eDNA, tagged with ltcmngglutinin. and sclccled by genetid n fo llowed by clonal selection . Transcription 
of an,giostatin mRNA was demonstrated by nT-PCR nnd expression of th e hemagglutinin tug by Western 
analysis. EOMA cell s trans fcctcd wi1h tht' angios1a1in ct)NA , v~c 1or :tlonc. or parental EOMA cells 
were injected :~ ubcuum~ous!y into tuhymic nude mice 10 cslal;Jish the model. By 5 days af1cr injection, 
hemangiomas were visil; l ~. However. by approximately 3 weeks after inj~ctlon , co!llrol mice died from 
hcmorrht1gc while mice with llllllOrs I h.'! I produced angiostmin rhrivcd withoul ;my signs of toxicily and 
wi th litnitcd 1hrombocytopct1ia. Al 2 1 days aflcr injection. con1rol1umor volumes ave raged t700 mm' 
vs. tumor volumes of 11 0 nun' i.n :mgioslmin-producing tumors. These studies show lhnt local 
production of angiostatin dr;nnat ically inhibits the growth of liftH hrcatcning hemangiomas without 
tox id cy. The amicumor :!ccivicy in1his immunadeficicnrmousc pro \'ides further evidence th .:u rhc action 
of angiostatiu docs not ilwo lvc T·cc\1 immune acllvation. Tumor delivery of :mgiostalin . either through 
protein introducli on or gene 1hcrapy, may revolutionize therapy of lifc·thrcatcning and even 
uncomplicated hcmang.iom<ts. 
